Note 3 - Newco4pharmacy Transaction (Details Narrative) - USD ($)		12 Months Ended
	Dec. 09, 2015	Dec. 31, 2015	Dec. 31, 2014
Conversion of Series X preferred stock to common stock, value			$ 24,750
N4P [Member]
Percentage of Business Acquired	100.00%	100.00%
Conversion of Series X preferred stock to common stock	10,000,000	10,000,000
Conversion of Series X preferred stock to common stock, value	$ 106,900	$ 106,900